Significant Revenue Growth
UFP's revenue grew 41% in the first quarter of 2025, with operating income increasing by 45% and EPS growing by 35% to $2.21.
Strong Performance in Medical Business
The medical business grew by 50%, driven by high demand in the safe patient handling space. Interventional and surgical infection prevention, orthopedics, and advanced wound care segments all grew by more than 25%.
Successful Acquisitions
Recent acquisitions have been performing well, with integrations on track and contributing significantly to growth. The AJR acquisition alone grew about 40% compared to last year.
Strategic Customer Agreements
Signed a key customer agreement providing exclusive manufacturing rights in the safe patient handling space through mid-2030, with expected investment and shared savings from moving operations to the Dominican Republic.
Expansion in the Dominican Republic
Continued progress on Dominican Republic expansion plans, including a new leased facility in Santiago, expansion of the La Romana Robotic Surgery campus, and new equipment installations for upcoming programs.
Positive Cash Flow and Debt Reduction
Generated $13.8 million in cash from operations, paid down approximately $7 million in debt, and ended the quarter with a leverage ratio below 1.5 times.